|
|
Volumn 360, Issue 9339, 2002, Pages 1095-1098
|
|
Methotrexate treatment and mortality in rheumatoid arthritis [1] (multiple letters)
a
h
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRHEUMATIC AGENT;
AUTOANTIBODY;
FOLIC ACID;
IMMUNOMODULATING AGENT;
IMMUNOSUPPRESSIVE AGENT;
METHOTREXATE;
NONSTEROID ANTIINFLAMMATORY AGENT;
TUMOR NECROSIS FACTOR ALPHA;
ANTIPHOSPHOLIPID SYNDROME;
AUTOIMMUNE DISEASE;
B CELL LYMPHOMA;
CALCULATION;
CARDIOVASCULAR RESPONSE;
COHORT ANALYSIS;
COMORBIDITY;
CONFIDENCE INTERVAL;
DEATH;
DISEASE ACTIVITY;
DISEASE SEVERITY;
DRUG WITHDRAWAL;
EPSTEIN BARR VIRUS;
FOLLOW UP;
FRANCE;
HODGKIN DISEASE;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LETTER;
LYMPHOCYTE PROLIFERATION;
LYMPHOPROLIFERATIVE DISEASE;
MORTALITY;
NONHODGKIN LYMPHOMA;
PRIORITY JOURNAL;
PROGNOSIS;
PROSPECTIVE STUDY;
QUANTITATIVE ANALYSIS;
RANDOMIZATION;
RHEUMATOID ARTHRITIS;
RISK FACTOR;
STATISTICS;
THROMBOSIS;
CARDIOVASCULAR DISEASE;
DRUG COMBINATION;
METHODOLOGY;
NOTE;
STANDARD;
SURVIVAL;
EPIDEMIOLOGY;
PROPORTIONAL HAZARDS MODEL;
STATISTICAL ANALYSIS;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
CARDIOVASCULAR DISEASES;
DRUG THERAPY, COMBINATION;
FOLIC ACID;
HUMANS;
METHOTREXATE;
RESEARCH DESIGN;
SURVIVAL ANALYSIS;
BIAS (EPIDEMIOLOGY);
DATA INTERPRETATION, STATISTICAL;
MORTALITY;
PROPORTIONAL HAZARDS MODELS;
|
|
EID: 0037027034
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(02)11156-1 Document Type: Letter |
|
Times cited : (9)
|
|
References (4)
|
